StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. AGLE has been the topic of several other research reports. Jonestrading restated a hold rating on shares of Aeglea BioTherapeutics in a research report on […]
Related Keywords
Aeglea Biotherapeutics , Charles Schwab Investment Management Inc , Wells Fargo Company , Aeglea Biotherapeutics Company Profile , Aeglea Biotherapeutics Inc , Goldman Sachs Group Inc , Ghost Tree Capital , Acadian Asset Management , Get Rating , Schwab Investment Management , Asset Management , Street Corp , Sachs Group , Tree Capital , Nasdaq Agle , Beagle , Medical , Initiated Coverage , Stocknews Com ,
vimarsana.com © 2020. All Rights Reserved.